One-Time Gene Therapy Shows Lasting Promise Against Huntington’s Disease Four Years Later
An experimental one-time gene therapy from biotech company uniQure continues to show signs of slowing Huntington’s disease four years after treatment, offering potentially important evidence that gene therapy could alter the course…
